GlaxoSmithKline

A vaccine to help prevent a leading cause of pneumonia in the elderly has been found effective in late-stage clinical trials.

GSK’s shingles vaccine will get a renewed marketing push following a large drop in sales during the pandemic, and the company is aiming to launch a fast-tracked shot for a common respiratory virus...

In total, 17.2 million adult vaccine doses were missed in 2020. And immunizations continue to lag well behind 2019 levels, reports GlaxoSmithKline.

A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...

Big pharmaceutical companies are exploring “brand personality” in their marketing strategies, according to new research.

The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.

Pharmaceutical giant GlaxoSmithKline will stop paying healthcare professionals to speak about its products, and will alter other marketing and compensation practices that are common in the industry but...

The discovery of a compound that stops diseases like Alzheimer’s and Parkinson’s in their tracks is a “landmark” step toward a pill to treat these conditions, according to researchers...

GlaxoSmithKline said it has received Food and Drug Administration approval to start shipping the 2013-2014 influenza virus vaccine to Centers for Disease Control and Prevention distribution centers and...

A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia. Many panelists, however, said precautions are still needed.